Senior execs of Aramco, SNB, eXtra, stc highest paid in 2023
Argaam Special21/04/2024
Osool & Bakheet issues Q1 2024 earnings forecast
Argaam20/04/2024
Argaam Special21/04/2024
Argaam20/04/2024
| Last Trade | 133.40 |
| Change | (0.60) |
| Change (%) | (0.45) |
| Open | 134.60 |
| Low | 132.40 |
| High | 135.40 |
| Prev. Close | 134.00 |
| Change (3M) | n/a |
| Change (6M) | n/a |
| Volume | 59,922 |
| Turnover | 8,026,617.00 |
| Transactions | 1,552 |
| Market Value | 2,668.00 |
| Avg. Volume (3M) | 437,548.09 |
| Avg. Turnover (3M) | 75,921,952.83 |
| Avg. Transaction (3M) | 6,395.16 |
| Change(12M) | n/a |
| YTD | n/a |
|
Event Date
|
Event
|
Venue
|
|
|---|---|---|---|
|
27-02-2024
|
listing date | - | |
|
14-02-2024
|
Surplus refund date | - | |
|
08-02-2024
|
Allocation Date | - | |
|
01-02-2024
|
IPO/ Subscription | - | |
|
30-01-2024
|
IPO/ Subscription | - | |
| more | |||
Argaam Special27/02/2024
Argaam25/02/2024
| Report | Interim | Year |
| Avalon Pharma turns to profit of SAR 9.4M in Q1 2024 | 3 M | 2024 |
| Avalon Pharma’s profit rises 11% to SAR 65.8M in 2023 | 12 M | 2023 |
Argaam14/04/2024
Argaam27/02/2024
| Date | Research firm | Rating |
|
|
GIB Capital | Overweight |
|
|
Al Rajhi Capital | Overweight |
|
|
SNB Capital | Overweight |
|
|
Forsa Financial | Initiation |